These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9610759)

  • 1. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surface-immobilized heparin on the activation of adsorbed factor XII.
    Elgue G; Sanchez J; Egberg N; Olsson P; Riesenfeld J
    Artif Organs; 1993 Aug; 17(8):721-6. PubMed ID: 8215954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the control of the plasma contact activation system on human endothelium: comparisons with heparin surface.
    Sánchez J; Olsson P
    Thromb Res; 1999 Jan; 93(1):27-34. PubMed ID: 10065896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood.
    Gerling K; Ölschläger S; Avci-Adali M; Neumann B; Schweizer E; Schlensak C; Wendel HP; Stoppelkamp S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32668719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I
    Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
    Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
    J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
    Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
    J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
    Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
    J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a heparin binding site on the heavy chain of factor XI.
    Zhao M; Abdel-Razek T; Sun MF; Gailani D
    J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces.
    Randriamahazaka HN; Nigretto JM
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):567-73. PubMed ID: 7841313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.